Supraglottic oxygen delivery through an endotracheal tube for ERCP under deep sedation
Official title: Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study
Run by Zhejiang University · NCT07051980 · Data updated 2026-11-12
This tests whether delivering oxygen just above the vocal cords through an endotracheal tube can prevent low oxygen levels in adults having ERCP with deep sedation.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | June 12, 2025 |
| Main results expected | December 2, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | July 17, 2025 |
| Trial ID | NCT07051980 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with ASA I–III who are scheduled for a sedated ERCP expected to last ≤45 minutes and who do not have severe cardiac, renal, or pulmonary disease and have BMI ≤30 kg/m².
✕Probably not a fit
Patients with COPD or other chronic pulmonary disease requiring oxygen, BMI >30 kg/m², severe cardiac or renal dysfunction, pregnancy or breastfeeding, active upper respiratory infections or fever, or those currently in other clinical trials are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a two-stage Phase II feasibility and safety study conducted at a single tertiary center to test supraglottic oxygen delivery via an endotracheal tube during non-intubated ERCP performed under deep sedation. Adult patients (≥18 years) with ASA I–III scheduled for an ERCP expected to last ≤45 minutes will receive the supraglottic oxygen device during the procedure and be monitored for hypoxia and other adverse events. Key exclusions include significant cardiac or renal dysfunction, COPD or other chronic pulmonary disease requiring oxygen, BMI >30 kg/m², pregnancy or active upper respiratory infection. The protocol focuses on whether this airway adjunct reduces the incidence of desaturation and is safe and feasible in this setting.
Why it matters
Potential benefit: If successful, this could reduce episodes of hypoxia during ERCP under deep sedation and lower cardiopulmonary complications.
How similar studies have gone: High-flow nasal oxygen and nasopharyngeal oxygenation have shown benefit in reducing desaturation during sedation, but using supraglottic oxygen delivery via an endotracheal tube for non-intubated ERCP is a relatively novel approach with limited prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years; * The ASA classification ranges from I to III. * Patients have signed the informed consent form. * Patients scheduled to undergo sedated ERCP examination; * The estimated duration of the procedure does not exceed 45 minutes. Exclusion Criteria: * Severe cardiac dysfunction (\<4 METs); * Severe renal insufficiency (requiring preoperative dialysis); * Diagnosed chronic obstructive pulmonary disease (COPD) or other acute/chronic pulmonary diseases requiring long-term/intermittent oxygen therapy; * Increased intracranial pressure; * Upper respiratory tract infections (oral/nasal/pharyngeal); * Fever (core temperature \>37.5°C); * Confirmed pregnancy or current breastfeeding; * Allergy to sedatives (e.g., propofol) or medical adhesives; * BMI \>30 kg/m²; * Current participation in other clinical trials;
Where it's running
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: DiSan Head of Anesthesiology, PhD
- Email: diansansu@yahoo.com
- Phone: +86 18616514088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
COMBO oropharyngeal airway during sedated ERCP
This test will see if the COMBO Endoscopy Oropharyngeal Airway reduces episodes of low oxygen (hypoxia) in adults undergoing ERCP with propofol sedation.
-
Electrosurgical Patterns and Learning Curve in Laparoscopic Gallbladder Surgery
This study observes how surgeon experience relates to patterns of electrosurgery use during elective laparoscopic gallbladder removal to see if experience affects intraoperative difficulty.
-
Improvised retrieval bag vs direct gallbladder extraction in laparoscopic cholecystectomy
This trial tests whether using an improvised retrieval bag to remove the gallbladder during laparoscopic cholecystectomy is as safe and effective as removing it directly without a bag in adults with gallbladder stones.
-
Short-stay aggressive hydration to prevent post-ERCP pancreatitis
This trial tests whether a short, high-volume IV hydration with Lactated Ringer's plus a rectal indomethacin can prevent post-ERCP pancreatitis in adults undergoing ERCP.
-
Time to Lose Consciousness With Remimazolam vs Propofol for Anesthetic Induction
This study tests whether remimazolam changes the time to loss of consciousness compared with propofol for anesthesia induction in adults undergoing elective laparoscopic gallbladder removal.
-
Phosphate therapy for adults with acute pancreatitis
This study tests whether giving phosphate through an IV can help adults with acute pancreatitis treated in the emergency department.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.